Home Schedule Location Speakers Sponsors
Saturday, November 17, 2018
Mike & Ophelia Lazaridis Quantum Nano Centre
Apply
Applications now open!
Featured Speakers
Cameron Piron
Keynote Speaker
Cameron Piron is an industry-recognized leader and innovator in image-guided surgery through his work at Synaptive Medical and Sentinelle Medical. Cameron studied systems design engineering at the University of Waterloo. His awards include being named to Canada’s Top 40 Under 40 list in 2009, which was established by Caldwell Partners and celebrates the achievements of young Canadians in the private, public and non-profit sectors; and being the first Canadian ever to win R&D Magazine’s Innovator of the Year award in 2008. He is a member of Synaptive’s Board of Directors.
Lane Desborough
Industry Panel
Degrees in chemical engineering from the University of Waterloo (1990) and Queen's University (1992) launched Lane's career at Nova Chemicals, Honeywell, and General Electric. His experience in industrial automation enabled him to jump into the fight against Type 1 diabetes when his son was diagnosed in 2009, first at Medtronic Diabetes and now as Co-Founder and Chief Engineer at Bigfoot Biomedical, where he leads algorithm development and data science.
Armen Bakirtzian
Industry Panel
Armen is the CEO and Co-Founder of Intellijoint Surgical, a Waterloo-based medical technology company focused on improving patient outcomes in joint replacement surgery. After developing Intellijoint’s core technology through their engineering capstone project and winning the Next Top Young Entrepreneur Start-Up Pitch Competition, Armen and his Co-Founders founded Intellijoint Surgical. Now fully commercialized, Intellijoint Surgical employs over 50 people and is selling its first product, intellijoint HIP®, globally.
Heather Ritch
Industry Panel
Heather Ritch is currently a Sr. Project Engineer at Johnson and Johnson’s only consumer manufacturing facility in Canada. Heather has over 15 years of experience in pharmaceutical manufacturing and has led several major engineering capital projects, which have increased plant capacity and upheld uniform quality standards enforced by the FDA. Heather holds a B.A.Sc. in Biological Engineering from the University of Guelph.
Lahav Gil
Industry Panel
Lahav is the CEO of RelayMedical, an integrated incubator/accelerator platform, developing a portfolio of medical technologies for pre-commercial exits in the healthtech marketplace. In 2003, Lahav founded Kangaroo Group, a full-spectrum outsourcing platform for medical device innovation, commercialization strategies, engineering, design, productization, regulatory submissions, and contract manufacturing. He has contributed to over 200 technology product launches and has lectured at multiple universities in Canada and Israel.
Sandeep Koshy
Breakout Speaker
Dr. Sandeep Koshy is an Investigator at the Novartis Institutes of Biomedical Research (NIBR) in Immuno-Oncology, where he leads a research program using engineered biomaterials for cancer immunotherapy. Dr. Koshy received his S.M. (2012) and Ph.D. (2017) in Engineering Sciences from Harvard University and his B.A.Sc. in Chemical Engineering from the University of Waterloo (2010). He has authored 23 peer-reviewed scientific publications and is an inventor on four United States patent applications.
David Kolesky
Breakout Speaker
David is a Technology Development Fellow at the Wyss Institute where he is developing technologies for tissue and organ replacement. He earned his Ph.D. in Dr. Jennifer Lewis’ lab at Harvard University, where he developed methods for 3D bioprinting vascularized, heterogeneous tissues. David earned a B.S. degree in Materials Science and Engineering from the University of Florida. Recently, David completed the Flagship Pioneering Venturelabs Fellows program where he was part of a venture creation team.
Teyden Nguyen
Breakout Speaker
Teyden Nguyen, a Master’s student at the University of British Columbia and University of Waterloo alumni, is an expert in bioinformatics. She is passionate about the movement towards a restructured healthcare system that implements personalized and precision medicine. Previously at Gene42, she developed software to aid clinician workflows in the assessment and diagnosis of rare genetic diseases. At the University of Waterloo, she performed research with the Rooney Lab and at the Center for Research & Education on Aging in UC Berkeley, and was also an organizer for Hack the North.
Aileen Zhou
Breakout Speaker
Aileen Zhou, Ph.D., is a Senior Regulatory Affairs Specialist at Synaptive Medical, a medical device company in the image-guided surgery space. She manages the regulatory activities of Synaptive’s flagship product portfolio in the global markets (including US, Canada, Europe and Asia Pacific). Aileen has over a decade of experience in the medical device industry and in translating research to commercial products having commercialized her Ph.D. research at Induce Biologics. Aileen studied at the University of Toronto where she earned a B.A.Sc. in Engineering Science and an M.S. and Ph.D. in Biotechnology.
Thanh Vuong
Breakout Speaker
Thanh is a Waterloo alumni (Systems Design Engineering ’98, Management Sciences ’01) and currently leads intellectual property (IP) efforts at Synaptive Medical. He is a registered US and Canadian patent agent, and an inventor on 50+ patents. Prior to Synaptive, Thanh spent 15 years at RIM / BlackBerry helping them grow their IP portfolio to 30K+ patents. Over the past 4 years, he has grown Synaptive’s IP portfolio from scratch to 900+ applications with 200+ grants.
Maura Grossman
AI in Medicine Panel Moderator
Maura R. Grossman, J.D., Ph.D., is a Research Professor in the School of Computer Science at the University of Waterloo. Her scholarly work on TAR, most notably, Technology-Assisted Review in E-Discovery Can Be More Effective and More Efficient Than Exhaustive Manual Review, published in the RICHMOND JOURNAL OF LAW AND TECHNOLOGY in 2011, has been widely cited in case law, both in the U.S. and elsewhere.
Philip Awadalla
AI in Medicine Panel
Dr. Philip Awadalla, PhD, is the National Scientific Director for the Canadian Partnership for Tomorrow Project and Professor of Population and Medical Genomics at the University of Toronto. He obtained his doctorate in population and statistical genetics from the University of Edinburgh and was awarded NSERC, Killam, and Wellcome Trust Fellowships to pursue his postdoctoral work before taking faculty positions at North Carolina and the University of Montreal. Major projects include genomics of aging, hematological diseases and cancers.
Sunit Das
AI in Medicine Panel
Dr. Sunit Das is a neurosurgeon and scientist at St. Michael’s Hospital and the Keenan Research Centre for Biomedical Science, and an Associate Professor in the Division of Neurosurgery at the University of Toronto. His research and clinical interests revolve around primary tumours of the brain. He is active in the Ethics community at the University of Toronto, and has a particular interest in understanding the processes the underlie the caregiver identity in medicine.
Cameron Piron
Keynote Speaker
Lane Desborough
Industry Panel
Armen Bakirtzian
Industry Panel
Heather Ritch
Industry Panel
Lahav Gil
Industry Panel
Sandeep Koshy
Breakout Speaker
David Kolesky
Breakout Speaker
Teyden Nguyen
Breakout Speaker
Aileen Zhou
Breakout Speaker
Thanh Vuong
Breakout Speaker
Maura Grossman
AI in Medicine Panel Moderator
Philip Awadalla
AI in Medicine Panel
Sunit Das
AI in Medicine Panel
Cameron Piron is an industry-recognized leader and innovator in image-guided surgery through his work at Synaptive Medical and Sentinelle Medical. Cameron studied systems design engineering at the University of Waterloo. His awards include being named to Canada’s Top 40 Under 40™ list in 2009, which was established by Caldwell Partners and celebrates the achievements of young Canadians in the private, public and non-profit sectors; and being the first Canadian ever to win R&D Magazine’s Innovator of the Year award in 2008.He is a member of Synaptive’s Board of Directors.
Degrees in chemical engineering from the University of Waterloo (1990) and Queen's University (1992) launched Lane's career at Nova Chemicals, Honeywell, and General Electric. His experience in industrial automation enabled him to jump into the fight against Type 1 diabetes when his son was diagnosed in 2009, first at Medtronic Diabetes and now as Co-Founder and Chief Engineer at Bigfoot Biomedical, where he leads algorithm development and data science.
Armen is the CEO and Co-Founder of Intellijoint Surgical, a Waterloo-based medical technology company focused on improving patient outcomes in joint replacement surgery. After developing Intellijoint’s core technology through their engineering capstone project and winning the Next Top Young Entrepreneur Start-Up Pitch Competition, Armen and his Co-Founders founded Intellijoint Surgical. Now fully commercialized, Intellijoint Surgical employs over 50 people and is selling its first product, intellijoint HIP®, globally.
Heather Ritch is currently a Sr. Project Engineer at Johnson and Johnson’s only consumer manufacturing facility in Canada. Heather has over 15 years of experience in pharmaceutical manufacturing and has led several major engineering capital projects, which have increased plant capacity and upheld uniform quality standards enforced by the FDA. Heather holds a B.A.Sc. in Biological Engineering from the University of Guelph.
Lahav is the CEO of RelayMedical, an integrated incubator/accelerator platform, developing a portfolio of medical technologies for pre-commercial exits in the healthtech marketplace. In 2003, Lahav founded Kangaroo Group, a full-spectrum outsourcing platform for medical device innovation, commercialization strategies, engineering, design, productization, regulatory submissions, and contract manufacturing. He has contributed to over 200 technology product launches and has lectured at multiple universities in Canada and Israel.
Dr. Sandeep Koshy is an Investigator at the Novartis Institutes of Biomedical Research (NIBR) in Immuno-Oncology, where he leads a research program using engineered biomaterials for cancer immunotherapy. Dr. Koshy received his S.M. (2012) and Ph.D. (2017) in Engineering Sciences from Harvard University and his B.A.Sc. in Chemical Engineering from the University of Waterloo (2010). He has authored 23 peer-reviewed scientific publications and is an inventor on four United States patent applications.
David is a Technology Development Fellow at the Wyss Institute where he is developing technologies for tissue and organ replacement. He earned his Ph.D. in Dr. Jennifer Lewis’ lab at Harvard University, where he developed methods for 3D bioprinting vascularized, heterogeneous tissues. David earned a B.S. degree in Materials Science and Engineering from the University of Florida. Recently, David completed the Flagship Pioneering Venturelabs Fellows program where he was part of a venture creation team.
Teyden Nguyen, a Master’s student at the University of British Columbia and University of Waterloo alumni, is an expert in bioinformatics. She is passionate about the movement towards a restructured healthcare system that implements personalized and precision medicine. Previously at Gene42, she developed software to aid clinician workflows in the assessment and diagnosis of rare genetic diseases. At the University of Waterloo, she performed research with the Rooney Lab and at the Center for Research & Education on Aging in UC Berkeley, and was also an organizer for Hack the North.
Aileen Zhou, Ph.D., is a Senior Regulatory Affairs Specialist at Synaptive Medical, a medical device company in the image-guided surgery space. She manages the regulatory activities of Synaptive’s flagship product portfolio in the global markets (including US, Canada, Europe and Asia Pacific). Aileen has over a decade of experience in the medical device industry and in translating research to commercial products having commercialized her Ph.D. research at Induce Biologics. Aileen studied at the University of Toronto where she earned a B.A.Sc. in Engineering Science and an M.S. and Ph.D. in Biotechnology.
Thanh is a Waterloo alumni (Systems Design Engineering ’98, Management Sciences ’01) and currently leads intellectual property (IP) efforts at Synaptive Medical. He is a registered US and Canadian patent agent, and an inventor on 50+ patents. Prior to Synaptive, Thanh spent 15 years at RIM / BlackBerry helping them grow their IP portfolio to 30K+ patents. Over the past 4 years, he has grown Synaptive’s IP portfolio from scratch to 900+ applications with 200+ grants.
Maura R. Grossman, J.D., Ph.D., is a Research Professor in the School of Computer Science at the University of Waterloo. Her scholarly work on TAR, most notably, Technology-Assisted Review in E-Discovery Can Be More Effective and More Efficient Than Exhaustive Manual Review, published in the RICHMOND JOURNAL OF LAW AND TECHNOLOGY in 2011, has been widely cited in case law, both in the U.S. and elsewhere.
Dr. Philip Awadalla, PhD, is the National Scientific Director for the Canadian Partnership for Tomorrow Project and Professor of Population and Medical Genomics at the University of Toronto. He obtained his doctorate in population and statistical genetics from the University of Edinburgh and was awarded NSERC, Killam, and Wellcome Trust Fellowships to pursue his postdoctoral work before taking faculty positions at North Carolina and the University of Montreal. Major projects include genomics of aging, hematological diseases and cancers.
Dr. Sunit Das is a neurosurgeon and scientist at St. Michael’s Hospital and the Keenan Research Centre for Biomedical Science, and an Associate Professor in the Division of Neurosurgery at the University of Toronto. His research and clinical interests revolve around primary tumours of the brain. He is active in the Ethics community at the University of Toronto, and has a particular interest in understanding the processes the underlie the caregiver identity in medicine.
Schedule
9:00 -   9:30
9:30 -   9:45
9:45 - 10:45
11:00 - 12:00
12:00 -   1:30
1:30 -   2:10
2:20 -   3:00
3:15 -   4:15
4:15 -   4:30
Registration and Refreshments
QNC Atrium
Opening Remarks
QNC 0101
Morning Keynote
QNC 0101 - Cameron Piron
Industry Panel
QNC 0101
Lunch and Poster Session
QNC Atrium
Breakout Speaker Session
QNC 1502 - David Kolesky
QNC 2502 - Aileen Zhou
Breakout Speaker Session
QNC 1502 - Sandeep Koshy
QNC 2502 - Teyden Nguyen
AI in Medicine Academic Panel
QNC 0101
Closing Remarks
QNC 0101
9:00
9:30
9:45
11:00
12:00
1:30
2:20
3:15
4:15
Registration
QNC Atrium
Opening Remarks
QNC 0101
Morning Keynote
QNC 0101 - Cameron Piron
Industry Panel
QNC 0101
Lunch and Posters
QNC Atrium
Breakout Speakers
QNC 1502 - David Kolesky
QNC 2502 - Aileen Zhou
Breakout Speakers
QNC 1502 - Sandeep Koshy
QNC 2502 - Teyden Nguyen
AI in Medicine Panel
QNC 0101
Closing Remarks
QNC 0101
Diamond Sponsors
Platinum Sponsors
Gold Sponsors
Questions? Email us at uwbiotec.main@gmail.com
©2018 UW BioTEC